Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel BACE inhibitors in early development at De Novo

Sep. 6, 2004

Neramexane fails to reach statistical significance in phase III Alzheimer's study

Sep. 3, 2004

New cannabinoid CB1/CB2 ligands and their use claimed by AstraZeneca

Sep. 3, 2004

Novel COX-1 inhibitors prepared and tested at Fujisawa

Sep. 3, 2004

FDA approval for Parcopa

Sep. 2, 2004

MitoKor presents adenine nucleotide translocase ligands and their use

Sep. 2, 2004

Favorable properties described for Neuropharma's novel thiazolidinediones

Sep. 1, 2004

SPA agreement for pivotal studies of Corlux

Sep. 1, 2004

Preoperative gabapentin reduces the need for analgesics following vaginal hysterectomy

Sep. 1, 2004

Forest submits Lexapro complete response for panic disorder

Aug. 31, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...